This clinical trial compares the efficacy of continuous glucose monitoring (CGM) vs traditional blood glucose meter monitoring on glycemic control in adults wit
By Bill Hathaway
May 25, 2021
Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this
(Illustration by Michael S. Helfenbein)
The primary function of the lung is to facilitate transfer of oxygen to the blood stream. Crucial to this lifegiving task are endothelial cells, which line blood vessels permeating the lung and through which gas exchange occurs.
Malfunction of these cells is implicated in a range of different diseases, including COPD (chronic obstructive pulmonary disease), pulmonary fibrosis, and pulmonary hypertension. And the COVID-19 pandemic has raised important questions about these cells: Why are some endothelium cells, particularly in the elderly, more susceptible to injury from the disease?
A reference map of endothelial cells in the lungs was created to help researchers identify specific abnormalities that occur in a host of lung diseases
Share this article
Share this article
RIDGEFIELD, Conn., April 23, 2021 /PRNewswire/ Boehringer Ingelheim today announced results from a phase III, randomized study that concluded that switching several times from Humira® (adalimumab) to Cyltezo® (adalimumab-adbm) produced similar clinical outcomes in terms of pharmacokinetics, efficacy, immunogenicity, and safety in people with moderate-to-severe chronic plaque psoriasis. The 32-week data will be presented at the American Academy of Dermatology 2021 virtual meeting experience. We are proud to present the results from Voltaire-X, a landmark study that supports Boehringer Ingelheim s application for interchangeability between Cyltezo® and Humira®, said Thomas Seck, Senior Vice President, Medicine and Regulatory Affairs at Boehringer Ingelheim. This first-of-its-kind switching study further reinforces our goal to broaden access to biosimilar treatment options while contributing to the quality and sustainability of healt